IQVIA Holdings Inc.
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3013% above fair value
$245.82−4.73 (-1.89%)
Close on Nov 20, 2026Market cap $40.51BP/E 29.9Yield –
Iqvia Net Debt (Form 8-K Leverage Table) by Quarter
Net Debt (Form 8-K Leverage Table) ($M)
Iqvia Net Debt (Form 8-K Leverage Table): $13,818M in Q3 2026, up 5.1% from a year earlier.
Latest, Q3 2026
13,818
Period ended Sep 30, 2026
Change on a year earlier
+5.1%
13,143 in Q3 2025
History
40 quarters
Since Q4 2016
Sources
40
Documents cited below
Where the Q3 2026 figure comes from
“|| Net Debt as of September 30, 2026 | $ | 13,818”
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up net Debt (Form 8-K Leverage Table)
Cite this data
StockData. (2026). Iqvia Net Debt (Form 8-K Leverage Table) ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Iqvia SEC filings and investor materials. https://stockdatahq.com/stocks/iqv/kpis/leverage-net-debt
See every metric in the Iqvia KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?